about
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision d...
Read More
4.64
-0.06
(-1.28%)
325.2K
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Alumis Inc. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..